Previous 10 | Next 10 |
NeoGenomics ([[NEO]] -0.6%) plans to open a state-of-the-art research laboratory by 2021 in China in association with the new lab PPD ([[PPD]] +0.1%) is opening in Suzhou.The NeoGenomics laboratory is expected to support Greater China-focused clinical trials and testing for global and local C...
NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials FORT MYERS, FL / ACCESSWIRE / October 13, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract resea...
The stock market is melting up despite a number of bearish developments including an increase in case counts, uncertainty with the upcoming election, and failure to reach agreement on a stimulus deal. However, savvy traders know that strong price action with bearish news flow means that trade...
FT. MYERS, FL / ACCESSWIRE / October 1, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its third quarter 2020 financial results on Tuesday, October 27, 2020. The Company has scheduled a webcast a...
Illumina's (ILMN) $8B takeout of liquid biopsy developer GRAIL, which it formed in 2016 with funding assistance from the likes of Bill Gates and Jeff Bezos, may be a watershed event for its use in cancer detection and management.It is developing a multi-cancer early detection test called Gall...
FT MYERS, FL / ACCESSWIRE / September 10, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that Doug VanOort, Chairman and Chief Executive Officer, Kathryn McKenzie, Chief Financial Officer and Doug Brown, Chief Strategy an...
FinancialBuzz.com News Commentary New York, NY (9/4/2020) – The diagnostics industry is a large and varied market, with new and innovative technology constantly being introduced. There are also various types of diagnostic methods including In Vitro Diagnostics (IVD), Point of Care (POC)...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
The coronavirus pandemic hit the business pretty hard, but NeoGenomics (NASDAQ: NEO) had been preparing investors for months. Properly setting expectations turned out to be a great move. Shares of NeoGenomics reached all-time highs shortly after the company announced second-quarter 2020 ope...
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its second quarter 2024 financial results after the close of the U.S. financial markets on Monday, July 29, 2024. Company management will host a webcast and conference call at 4:30 ...
2024-06-23 10:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that Fort Myers’ Mayor, Kevin Anderson, will be dedicating June as NeoGenomics’ Commitment to Cancer Month to honor cancer survivors and those currently living with cancer. Headquartered in...